Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Change in Receivables (2017 - 2025)

Catheter Precision (VTAK) has disclosed Change in Receivables for 9 consecutive years, with $8000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Receivables rose 300.0% to $8000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $16000.0, a 73.77% decrease, with the full-year FY2024 number at -$67000.0, down 201.52% from a year prior.
  • Change in Receivables was $8000.0 for Q3 2025 at Catheter Precision, down from $29000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $91000.0 in Q4 2023 to a low of -$83000.0 in Q3 2021.
  • A 5-year average of $526.32 and a median of $9000.0 in 2022 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: crashed 8400.0% in 2021, then soared 533.33% in 2023.
  • Catheter Precision's Change in Receivables stood at $51000.0 in 2021, then tumbled by 141.18% to -$21000.0 in 2022, then skyrocketed by 533.33% to $91000.0 in 2023, then plummeted by 140.66% to -$37000.0 in 2024, then surged by 121.62% to $8000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Change in Receivables are $8000.0 (Q3 2025), $29000.0 (Q2 2025), and $16000.0 (Q1 2025).